Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05665244 · ClinicalTrials.gov registry record
Laryngeal Cryotherapy for Refractory Neurogenic Cough
A clinical trial of Upper-Airway Cough Syndrome, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT05665244: Recruiting study of Upper-Airway Cough Syndrome, sponsored by University of Texas Southwestern Medical Center.
NCT05665244 is a study of Upper-Airway Cough Syndrome that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05665244, a study of Upper-Airway Cough Syndrome, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure
Primary Outcome
This is a validated patient reported outcome measure for chronic cough. This is a questionnaire of 10 questions about cough symptoms, each question is rated on a scale of 0-4 by the patient. The higher the CSI total score the worsen the cough symptoms are for the patient. The CSI will be compared across 5 time points (Pre-Laryngeal Cryotherapy, 1 week post cryotherapy, 1 month post cryotherapy, 3 months post cryotherapy and 6 months post cryotherapy) using repeated measures one-way ANOVA. Post-h
Conditions Studied
Interventions
- PROCEDURE Laryngeal cryotherapy
- DEVICE Cryoprobe
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-12-26 |
| Est. Completion | 2027-02 |
What NCT05665244 shows while recruiting
NCT05665244 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 1 condition, with Upper-Airway Cough Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Laryngeal cryotherapy is the first listed.
NCT05665244 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05665244 about?
NCT05665244 is a clinical study titled "Laryngeal Cryotherapy for Refractory Neurogenic Cough". This study aims to evaluate the safety and efficacy of upper aerodigestive tract cryotherapy treatment in patients with refractory neurogenic cough in a prospective pilot study with a validated patient reported outcome measure
What is the current status of trial NCT05665244?
This trial is currently recruiting. The enrollment target is 28 participants. The study started on 2022-12-26. Estimated completion is 2027-02.
What conditions does trial NCT05665244 study?
This clinical trial studies the following conditions: Upper-Airway Cough Syndrome.
What interventions are being tested in trial NCT05665244?
The interventions under investigation include: Laryngeal cryotherapy (PROCEDURE), Cryoprobe (DEVICE).
Who is sponsoring clinical trial NCT05665244?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05665244 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI